What is hemodialysis profiling?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemodialysis Profiling

Hemodialysis profiling refers to the systematic variation of dialysis treatment parameters during a single dialysis session, most commonly involving modulation of dialysate sodium concentration (sodium profiling) or ultrafiltration rate (ultrafiltration profiling), with the goal of reducing intradialytic symptoms and improving hemodynamic stability. 1, 2

Core Concept

Profiled hemodialysis (PHD) involves pre-programmed changes to dialysis parameters throughout the treatment session rather than maintaining constant settings. 2 The technique emerged to address intradialytic complications, particularly in high-risk patients with cardiovascular disease who experience vascular instability syndrome. 2

Types of Profiling

Sodium Profiling

  • Involves continuous modulation of dialysate sodium concentration throughout the extracorporeal session to antagonize changes in intradialytic plasma osmolarity. 2
  • Typically uses higher dialysate sodium concentrations in the first half of the session (when plasma osmolarity changes are greatest) to reduce the sodium removal rate, then adjusts to achieve the desired individual sodium balance by session end. 2, 3
  • Mathematical algorithms can determine rational sodium profiles a priori before each session, respecting individual sodium mass removal and weight gain requirements. 3

Ultrafiltration Profiling

  • Involves varying the ultrafiltration rate during the dialysis session rather than maintaining a constant rate. 4
  • Often combined with sodium profiling to reduce hemodialysis-related symptoms. 4

Blood Volume Monitoring

  • Uses intradialytic blood volume monitoring to guide treatment adjustments, though this approach is associated with higher mortality and hospitalization rates compared to conventional clinical monitoring. 1

Physiological Mechanism

Profiling aims to maintain more stable intradialytic blood volume and hemodynamics by reducing the rate of change in blood volume, particularly in the first half of the dialysis session. 2, 4 The technique reduces the slope of the blood volume curve during dialysis (standard: -2.96%/h versus profiled: -1.96%/h), which correlates with improved cardiovascular tolerance to ultrafiltration. 4

Clinical Evidence and Current Recommendations

Efficacy Data

  • Combined sodium and ultrafiltration profiling reduces symptomatic dialysis sessions from 30.6% to 20.4% (odds ratio 0.61,95% CI 0.39-0.96). 4
  • Profiling is associated with lower symptom scores during both intradialytic and interdialytic periods. 4
  • The technique maintains more stable blood pressure and heart rate throughout the session compared to standard hemodialysis. 2

Critical Guideline Warnings

Despite some symptomatic benefits, current guidelines explicitly recommend AGAINST routine use of profiling techniques due to significant safety concerns. 1

  • Sodium profiling is associated with increased all-cause mortality and should not be used routinely. 1
  • The technique results in sodium loading, hypervolemia, increased thirst, and greater interdialytic weight gain (0.3 kg higher predialysis weight). 1, 4
  • KDOQI guidelines explicitly state that increasing positive sodium balance by sodium profiling or using high dialysate sodium concentration should be avoided (Grade B recommendation). 1
  • Blood volume monitoring for routine profiling is associated with higher mortality and hospitalization rates. 1

Common Pitfalls

  • Do not implement routine blood volume monitoring based on older literature—the CLIMB trial demonstrated harm with this approach. 1
  • Avoid routine sodium profiling given the DOPPS mortality data; reserve it only for highly selected cases with severe intradialytic hypotension unresponsive to other interventions. 1
  • Recognize that interdialytic weight gain exceeding 4.8% of body weight is associated with increased mortality, and profiling techniques that promote positive sodium balance exacerbate this risk. 1
  • Understand that poor volume control from positive sodium balance worsens hypertension and cardiovascular outcomes in dialysis patients. 1

Alternative Approaches

Rather than using profiling, optimize volume management through adequate ultrafiltration to achieve euvolemia, counsel patients on sodium restriction to ≤5 g sodium chloride (2.0 g or 85 mmol sodium) daily, and consider cooling dialysate temperature to 0.5°C below body temperature for hemodynamic stability. 1

References

Guideline

Intradialytic Profiling Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical use of profiled hemodialysis.

Artificial organs, 1998

Research

An algorithm for the rational choice of sodium profile during hemodialysis.

The International journal of artificial organs, 1997

Research

Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms.

Journal of the American Society of Nephrology : JASN, 2001

Related Questions

What actions should be taken when a dialysis patient with an AVF (Arteriovenous Fistula) experiences hypotension?
Is it safe to perform a hemodialysis (HD) profiling session in a patient with severe hypertension and dyspnea?
What measures can help prevent post-dialytic syndrome in a patient's first hemodialysis session?
What is the optimal approach to manage hemodialysis?
What considerations are necessary for a hemodialysis (HD) consultation for a patient already on hemodialysis (HD) three times a week (MWF)?
What is the appropriate oral calcium supplementation dose per kilogram for a healthy 5‑year‑old child?
Could you create a PowerPoint presentation on recent advances in obstetric anaesthesia?
What is the appropriate evaluation and management of a branchial cleft cyst presenting as a painless lateral neck mass?
I am a 35‑year‑old white female with systemic lupus erythematosus, small‑fiber neuropathy, migraines, musculoskeletal pain and dysautonomia; when I take my nighttime medications and do not lie down immediately or awaken during the night, I experience orthostatic hypotension. May I share my full medication list for you to assess which drugs might be causing this?
In a patient with uncomplicated acute gastroenteritis, stable vital signs, normal white blood cell count (8000/µL) and mildly elevated C‑reactive protein (38 mg/L), which parenteral antibiotics, if any, should be administered?
In a chronic hemodialysis patient presenting with dyspnea, pulmonary congestion, and inspiratory crackles, should I perform detailed volume‑status profiling during the dialysis session?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.